Publications by authors named "Inaas Shirazi"
A Recurring Theme: A Rare Case of Pembrolizumab-induced Acute Interstitial Nephritis.
J Community Hosp Intern Med Perspect
July 2024
Article Synopsis
- Pembrolizumab is an immune checkpoint inhibitor used to treat various cancers, such as lung cancer and melanoma, by blocking the PD-1 pathway.
- Although it is effective, Pembrolizumab can cause side effects across different organ systems, one of which is acute interstitial nephritis (AIN).
- A case study discusses a 79-year-old male with metastatic squamous cell carcinoma who experienced recurring AIN following treatment with Pembrolizumab.